AJ
GILD icon

Ashburton (Jersey)’s Gilead Sciences GILD Stock Holding History

Ashburton (Jersey)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,177
Closed -$729K – 63
2016
Q4 		$729K Hold
10,177
– – 0.31% 61
2016
Q3 		$805K Sell
10,177
-10,758
-51% -$874K 0.37% 61
2016
Q2 		$1.75M Sell
20,935
-6,935
-25% -$615K 0.73% 37
2016
Q1 		$2.56M Buy
27,870
+1,060
+4% +$95.6K 0.9% 30
2015
Q4 		$2.74M Buy
+26,810
New +$2.79M 0.73% 41

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Ashburton (Jersey)'s GILD Position: Q1 2017 in Review

Ashburton (Jersey) sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 10,177 shares — an estimated $729K sold.

Ashburton (Jersey) first reported a position in GILD in Q4 2015 and held it in 5 quarters. The position peaked at $2.74M in Q4 2015. 1,526 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Ashburton (Jersey) reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • Ashburton (Jersey) sold 10,177 Gilead Sciences shares in Q1 2017, an estimated $729K.
  • Ashburton (Jersey) first reported a position in Gilead Sciences in Q4 2015 and held it in 5 quarters.
  • Ashburton (Jersey)'s Gilead Sciences position peaked at $2.74M in Q4 2015.
  • 1,526 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Ashburton (Jersey)'s 13F filing for Q1 2017, filed 18 May 2017.